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Lactobacillus rhamnosus GG is of general interest as a probiotic. Although L. rhamnosus GG is often used in
clinical trials, there are few genetic tools to further determine its mode of action or to develop it as a vehicle
for heterologous gene expression in therapy. Therefore, we developed a reproducible, efﬁcient electroporation
procedure for L. rhamnosus GG. The best transformation efﬁciency obtained was 10
4 transformants per go f
DNA. We validated this protocol by tagging L. rhamnosus GG with green ﬂuorescent protein (GFP) using the
nisin-controlled expression (NICE) system. Parameters for overexpression were optimized, which allowed
expression of gfp in L. rhamnosus GG upon induction with nisin. The GFP
 strain can be used to monitor the
survival and behavior of L. rhamnosus GG in vivo. Moreover, implementation of the NICE system as a gene
expression switch in L. rhamnosus GG opens up possibilities for improving and expanding the performance of
this strain. The GFP-labeled strain was used to demonstrate that L. rhamnosus GG is sensitive to human
beta-defensin-2 but not to human beta-defensin-1.
Increasing consumer awareness of health-promoting intesti-
nal bacteria has increased the use of probiotic bacteria as
functional ingredients in certain foods, most commonly dairy
products (19). Probiotics are deﬁned as live microorganisms
which, when adequate amounts are administered, provide a
health beneﬁt to the host beyond basic nutrition (11, 12).
Although the concept of probiotics is becoming established in
medicine and the food and feed industry, the underlying sci-
entiﬁc framework needs to be strengthened (44). A great num-
ber of trials have suggested beneﬁcial effects of probiotics (10,
22, 24, 32, 41, 45). Nevertheless, the basic molecular mecha-
nisms underlying the observations have not been completely
determined yet (40, 44). A prerequisite for thoroughly address-
ing the mode of action of a probiotic strain is amenability to
genetic analysis (46).
Lactobacillus rhamnosus GG ( ATCC 53103) (53), which
was isolated from a naturally occurring healthy human gut
ﬂora, is one of the most extensively studied probiotic organ-
isms (16, 23, 49). However, our understanding of the physiol-
ogy and genetics of this bacterium is still limited, mainly due to
the absence of a reliable transformation procedure. In the past
decade electroporation has become the method of choice for
transforming lactobacilli (34). The efﬁciencies of electropora-
tion between different Lactobacillus species and even between
strains belonging to the same species can vary signiﬁcantly
(34). Another difﬁculty in the development of a transformation
procedure is choosing the plasmid used. Indeed, the ability of
a plasmid to replicate and to express its selectable marker in a
given species cannot be predicted and inﬂuences the transfor-
mation frequency (52). The objective of the present study was
to develop a reproducible electroporation procedure for L.
rhamnosus GG. We adapted the previously described proce-
dure for electrotransformation of L. rhamnosus 1/6 (56). The
optimized protocol was used to increase the arsenal of genetic
tools for L. rhamnosus GG with the green ﬂuorescent protein
(GFP). The ﬁrst report describing GFP labeling of Lactobacil-
lus was made by Geoffroy et al. in 2000 (15). Since then, other
GFP-labeled lactic acid bacteria have been described (17, 25,
43). A GFP-labeled Lactobacillus plantarum strain was ob-
tained by using the nisin-controlled expression (NICE) system
initially developed for Lactococcus lactis (4). After addition of
subinhibitory amounts of the signaling molecule nisin (7), the
two-component NisRK system drives expression of GFP under
control of the nisin-inducible nisA promoter (4). The NICE
system has been used successfully for a variety of lactic acid
bacteria (9, 26, 29, 42). In this study, we used the optimized
electroporation protocol to implement the NICE system in L.
rhamnosus GG in order to tag L. rhamnosus GG with the green
ﬂuorescent protein. The GFP-tagged strain was used to deter-
mine the sensitivity of L. rhamnosus GG to human beta-de-
fensins.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. All strains were grown at 37°C.
L. rhamnosus GG was inoculated from a glycerol stock (80°C) into Man-
Rogosa-Sharpe (MRS) medium (Difco) and grown in static conditions. Esche-
richia coli was grown with aeration in Luria-Bertani broth (47). When appropri-
ate, antibiotics were added to the culture medium. For Lactobacillus, erythromycin
and chloramphenicol were used at ﬁnal concentrations of 5 and 10 g/ml, respec-
tively. In case of E. coli, antibiotics were supplied at following ﬁnal concentrations:
ampicillin, 100 g/ml; kanamycin, 30 g/ml; erythromycin, 250 g/ml; and chloram-
phenicol, 30 g/ml.
Molecular methods. Standard protocols were used for buffer preparation,
cloning, plasmid isolation, preparation of E. coli competent cells, and transfor-
mation (47). Restriction enzymes were used according to the manufacturer’s
instructions. Southern hybridization was carried out using a nonradioactive
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4923labeling and detection system, as previously described (47). DNA sequences were
determined by the dideoxynucleoside triphosphate chain termination method
(48) with an AutoRead sequencing kit (Pharmacia-LBK) and an automated
sequencer (ALX; Pharmacia-LBK). PCR primers were purchased from Eurogentec.
PRO-12 (5-ATGAATTCGGTCAGGATGATGCTATTAACC-3) and PRO-13
(5-ATGAATTCGCACCGTTAACTCCTAATAAACC-3) (EcoRI recognition
sites are underlined) were used for construction of pFAJ1934 (see below);
RHI-144 (5-ATTAGAAATGAGAAACTATGAAGTTGC-3) and RHI-145
(5-TACTCCTAATCTGATAAATATACTCCG-3) are homologous to the 5
and 3 regions of nisR; RHI-146 (5-AATTTTCAAGCCGTTCAAAAGATTG
C-3) and RHI-147 (5-ATTAACAAAGATATTGATAAGTGCTCG-3) are
homologous to the 5 and 3 regions of nisK; and RHI-148 (5-AACTTTTCAC
TGGAGTTGTCC-3) and RHI-149 (5-TAATGGTCTGCTAGTTGAACG-3)
are homologous to the 5 and 3 regions of gfpuv. If single colonies of L. rham-
nosus GG were used, the colony smeared in a PCR tube was heated in a
microwave oven at full power for 3 min before the PCR mixture was added. The
PCR was carried out with a Personal Mastercycler (Eppendorf) used according
to the manufacturer’s instructions. Integration of pMEC10 at the tRNA
Ser locus
and integration of pFAJ1934 at the tRNA
Leu locus were conﬁrmed by PCR and
Southern blotting, as previously described (1, 8). The following primers were
used: PRO-567 (5-GTCGACACAGGATTTGAACC-3; corresponding to
primer T2 [8]) and PRO-570 (5-CAAGCCAACAGACGTGCAAGCA-3;
binding to the 3 end of the int gene [8]) for tRNA
Ser integration and PRO-564
(5-AGCAGGACGAGAAAGCAATGAATGT-3; corresponding to primer
att1 [1]) and PRO-565 (5-GCCGGTGTGGCGGAATTGGCAG-3; corre-
sponding to primer att7 [1]) for tRNA
Leu integration.
Construction of pFAJ1934. The nisRK genes were ampliﬁed by PCR with the
proofreading Pfx enzyme (Invitrogen) used according to the manufacturer’s
instructions and primers PRO-12 and PRO-13, using pMEC10 as the template
DNA. The 2,634-bp fragment obtained, containing the nisR promoter, was di-
gested with EcoRI and ligated into the corresponding unique site of pEM40.
PCR, restriction, and sequence analysis conﬁrmed the localization of nisRK
downstream of the erythromycin resistance (ery) gene. The plasmid was desig-
nated pFAJ1934 and introduced into E. coli for propagation and subsequent
plasmid DNA isolation. In pFAJ1934, the nisRK genes are localized downstream
of the ery gene of pEM40, in the opposite orientation. This orientation of the
nisRK genes prevents read-through transcription of ery, which lacks a functional
transcription terminator (42) and allows low levels of expression of nisRK, which
is required for a functional inducible expression system. Indeed, in order to
retain the inducibility to nisin without a signiﬁcant increase of basal activity, low
levels of expression of nisRK are necessary (42).
Preparation of L. rhamnosus GG electrocompetent cells. An overnight culture
of L. rhamnosus GG was serially diluted (10
2-t o1 0
6-fold) into freshly prepared
prewarmed MRS medium supplemented with 2% glycine and was incubated
without agitation at 37°C. After overnight growth, 5 ml of the culture in the
exponential growth phase (optical density at 600 nm [OD600], 0.8 to 1) was
inoculated into 100 ml of freshly prepared, prewarmed MRS medium supple-
mented with 2% glycine. The resulting culture, which was kept in a tightly closed
100-ml Duran bottle (to minimize oxygen transfer), was incubated without agi-
tation at 37°C. When the OD600 was 0.2 to 0.3, ampicillin was added to obtain a
ﬁnal concentration of 10 g/ml (57). Then the cells were incubated until the
OD600 was 0.4 to 0.5. This optical density should have been reached within 3 to
TABLE 1. Bacterial strains, plasmids, and primer sequences used for PCR
Strain or plasmid Relevant genotype and/or phenotype
a Source and/or
reference
Strains
E. coli TOP10F F lacI
q Tn10(Tet
r) mcrA (mrr-hsdRMS-mcrBC) 	80lacZM15 lacX74 deoR recA1
araD139 (ara-leu)7697 galU galK rpsL (Str
r) endA1 nupG
Invitrogen
E. coli GM2163 Dam
/Dcm
;F
 ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6
hisG4 rfbD1 rpsL136(Str
r) dam13::Tn9(Cam
r) xylA5 mtl-1 thi-1 mcrB1 hsdR2;C m
r
New England
BioLabs Inc.
FAJ1905 L. rhamnosus GG with chromosomal insertion of pMEC10 in the attB sequence of phage
mv4; Ery
r
This study
FAJ1906 L. rhamnosus GG with chromosomal insertion of pFAJ1934 in the attB sequence of
phage A2; Ery
r
This study
L. casei ATCC 393 Wild type; cheese isolate American Type
Culture Collection,
Rockville, MD
L. rhamnosus 1/6 Wild type; cheese isolate Valio Ltd.
L. rhamnosus GG Wild type; human isolate ATCC 53103 (53)
Plasmids
pEM40 pUC19E-derived integration vector (attB located at the 3 end of the tRNA
Leu locus)
containing a 1.6-kb int-attP cassette of phage A2; Ery
r Amp
r
1
pFAJ1934 2,634-bp PCR fragment (ﬂanking EcoRI sites) carrying the nisRK genes of pMEC10
cloned into the EcoRI site of pEM40 downstream of the ery gene in the opposite
orientation; Ery
r Amp
r
This study
pGK13 Shuttle vector between E. coli and Lactococcus lactis; pWV01 replicon; Ery
r Cm
r 27
pLAB1301 L. hilgardii pLAB1000 replicon; shuttle vector between E. coli and L. plantarum;
Ery
r Cm
r
21
pMEC10 Integration plasmid (attB located at the 3 end of the tRNA
Ser locus) containing int-attP
cassette (of phage mv4) of pMC1 cloned into pNZ9500 (pUC19 derivative carrying a
2.7-kb chromosomal DNA fragment of L. lactis NZ9700 containing the 3 end of
nisP and nisRK); expression driven by ery read-through; Ery
r
42
pMEC30 L. hilgardii pLAB100 replicon; gfpuv cloned in expression vector containing the
constitutive ldhL promoter from L. plantarum; Ery
r Amp
r
15
pMEC45 L. lactis pSH71 replicon; pNZ8037 derivative with gfpuv cloned downstream of the
nisA promoter from L. lactis NZ9800; Cm
r
15
pNZ8008 pNZ273 (pSH71 replicon) carrying the E. coli gusA reporter gene transcriptionally fused
to the nisA promoter; Cm
r
28, N1Z0
pRV85 gfpuv cloned downstream of the L. sakei ldhL promoter in the replicative plasmid
pGhost5; Ery
r
17
a gfpuv, synthetic GFP gene (with improved codon usage) that was subsequently subjected to recursive cycles of DNA shufﬂing, thereby selecting for bright
ﬂuorescence that could be observed under UV light.
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competent cells. Cells were harvested by centrifugation at room temperature (10
to 15 min, 6,000 
 g). The cells were washed twice at room temperature with
electroporation buffer (0.5 M sucrose, 7 mM potassium phosphate [pH 7.4], 1
mM MgCl2) (2), resuspended in 1 ml of the same buffer, and placed on ice. The
electrocompetent cells were used immediately for electroporation. After 16 h of
freezing at 80°C, a slight decrease in the electrocompetency of the cells was
noticed, but after 1 week of storage, no transformants could be obtained.
Electroporation of L. rhamnosus GG. A mixture containing 100 l of a cooled
cell suspension and 400 ng of DNA (maximum volume, 4 to 5 l) was transferred
into a precooled electroporation cuvette (Eurogentec) with a 0.2-cm electrode
gap and immediately electroporated (Gene Pulser; Bio-Rad Laboratories) by
using the following settings: peak voltage, 1.7 kV; capacitance, 25 F; and
parallel resistance, 200 . Following the pulse, the cells were immediately diluted
with 5 ml of MRS medium containing 2 mM CaCl2 and 20 mM MgCl2 and
incubated (without agitation) at 37°C for 3 h before they were plated onto MRS
agar containing the appropriate antibiotic. The transformation efﬁciency was
assessed by determining the number of transformants per microgram of plasmid
DNA after anaerobic incubation (BBL GasPak system) at 37°C for 48 to 72 h.
Transformants were validated either by restriction digestion (after plasmid iso-
lation and back-transformation to E. coli) or by colony PCR.
Isolation of L. rhamnosus GG DNA. Total DNA of L. rhamnosus GG was
isolated as previously described for Rhodococcus (36), with following modiﬁca-
tions. Prewarmed MRS medium (freshly prepared) was inoculated with ca. 2 

10
8 CFU of an overnight culture of L. rhamnosus GG. After 2 to3ho fgrowth
without agitation at 37°C, 600 g/ml ampicillin was added to the culture, which
was then incubated for another 2 to 3 h. Bacterial cells were washed with
Tris-EDTA buffer (10 mM Tris, 1 mM EDTA; pH 8.0) and treated with lysozyme
(2 mg/ml; Sigma) at 37°C for 30 min. The cells were lysed further by addition of
sodium dodecyl sulfate (ﬁnal concentration, 1%) and NaCl (ﬁnal concentration,
1 M). RNase A (ﬁnal concentration, 35 g/ml; Sigma), prepared as described by
Sambrook et al. (47), was added, and this was followed by 15 min of incubation
at 55°C. The remainder of the protocol has been described previously (36). The
precipitated DNA was resuspended at 4°C for 48 to 72 h. Total DNA was stored
at 4°C. For isolation of plasmid DNA from L. rhamnosus GG, the protocol used
for isolation of total DNA was used, with some minor adaptations. After sodium
dodecyl sulfate and NaCl were added, the mixture was incubated at 20°C for
1 h. Cell wall components and degraded total DNA were removed by centrifu-
gation, after which the procedure used for isolation of total DNA was used.
Microtiter plate -glucuronidase assay to optimize nisin induction. Nisin-
induced expression of gusA (pNZ8008) (28) was optimized essentially as de-
scribed by Pavan et al. (42), except that strain L. plantarum NCIMB8826 was
replaced by L. rhamnosus GG FAJ1905. pNZ8008 (28) was introduced into
FAJ1905 by using the optimized electroporation protocol described above.
-Glucuronidase assays were performed by the method described by de Ruyter
et al. (4), modiﬁed as described by Miller (35), which resulted in the following
optimized microtiter plate-based protocol. After appropriate induction, 1 ml of
cells was harvested by centrifugation (5 min, 5,000 
 g) and resuspended in 500
l of NaPi buffer (50 mM NaHPO4, pH 7.0). After the OD595 of 135 l was
determined, cell suspensions were frozen at 80°C in 10-l aliquots in 96-well
plates until they were assayed for -glucuronidase activity. To each 10-l cell
suspension, 90 l of GUS buffer (50 mM NaHPO4 [pH 7.0], 14.3 mM
-mercaptoethanol, 1 mM Na2EDTA, 0.1% Triton X-100, 0.1% sodium lauryl-
sarcosine, 25 mM p-nitrophenyl--D-glucuronic acid [PNPG] [Sigma]) was
added. The mixture was incubated at 37°C. The reaction was stopped by adding
35 lo fa1MN a 2CO3 solution after sufﬁcient yellow color had developed. The
reaction was stopped at at least three different times (replicates) to ascertain that
enzyme activity was still linearly increasing with incubation time. The reaction
time was recorded. Both OD415 and OD595 were determined. Identical treat-
ments were performed with NaPi buffer but without cells as controls to correct
measured sample values. Miller units (MU) of -glucuronidase activity were
deﬁned as 1,000 times the increase in absorbance at 415 nm per minute per unit
of optical density at 595 nm of the cell suspension, as follows: MU  1,000 

{[(OD415,PNPG  1.75 
 OD595,PNPG) 
 v1]/(t 
 vt 
 OD595)}, where t is the
time of the reaction (in minutes), OD595 is a measure of cell density just before
the assay, OD415,PNPG is the absorbance by PNPG measured after the reaction,
OD595,PNPG is a measure of the cell density after the -glucuronidase reaction
(used as a correction for light scattering by cell debris), 1.75 is the corresponding
correction factor, v1 is the volume (in l) of cells used in the reaction mixture,
and vt is the total volume (in l) of the reaction mixture. The statistical analysis
was based on at least three independent repetitions, as designed in the optimi-
zation experiment. Optical densities were determined with a microtiter plate
reader (VERSAmax; Molecular Devices).
Expression of gfp under control of the nisin promoter. Expression of gfp driven
by the nisA promoter (pMEC45) in L. rhamnosus GG was optimally induced as
follows. An overnight culture of L. rhamnosus GG FAJ1905/pMEC45 or
FAJ1906/pMEC45 was used to inoculate fresh, prewarmed MRS medium di-
luted 1:50. After 30 min of incubation at 37°C without shaking, 500 ng/ml nisin
was added to the culture, which was then incubated for 2.5 to 3 h. Nisin was
prepared as previously described (9).
Epiﬂuorescence microscopy and ﬂow cytometric analysis. Fluorescence mi-
croscopy was performed as previously described (58). Flow cytometric analysis
was performed with a FACSCalibur (Becton Dickinson, Erembodegem, Bel-
gium) equipped with a 15-mW, air-cooled argon ion laser excitation light source
(488 nm), as previously described (31, 55). For two-color analysis, ﬂuorescence
compensation was used to correct for spectral overlap of the green and red
signals. Data were analyzed using CellQuestPro (Becton Dickinson).
Human beta-defensin sensitivity assay. L. rhamnosus GG cells were induced
with nisin as described above and collected by centrifugation, and ca. 10
6 CFU
was resuspended in 45 l of sixfold-diluted Dulbecco’s modiﬁed Eagle’s medium
(Gibco, Invitrogen) supplemented with 16.67 mM glucose. Subsequently, 5 lo f
human beta-defensins (Peptides International, Inc., Louisville, KY) dissolved in
10 mM acetic acid was added. For human beta-defensin-2 (hBD2), ﬁnal concen-
trations ranging from 0 to 12 g/ml were tested. For hBD1, a ﬁnal concentration
of 12 g/ml was used. After3ho fincubation at 37°C, bacterial viability was
measured either by plating serial dilutions on MRS agar or by ﬂow cytometry
using the green ﬂuorescent protein-propidium iodide (PI) assay as previously
described (31). Each experiment was performed in triplicate.
RESULTS AND DISCUSSION
Optimization of the electroporation protocol. The optimiza-
tion strategy used for electroporation is shown in Fig. 1. Ini-
tially, pGK13 (27) was used as the DNA source, which resulted
in an efﬁciency of 10
3 CFU/g DNA after some optimization
(Fig. 1). The optimal pulse strength was 8.5 kV cm
1, which is
higher than the optimal pulse strength in the protocol de-
scribed by Varmanen et al. (7.5 kV cm
1) (56) but lower than
the optimal pulse strength described by Wei et al. (12.5 kV
cm
1) (57), indicating that optimization of conditions for elec-
trotransformation is necessary for each species or even for
each strain of lactic acid bacteria. However, pGK13 seemed
to be segregationally unstable in L. rhamnosus GG, and the
results were not reproducible (data not shown). Plasmid
pLAB1301 (21), which contains the replicon of a native plas-
mid isolated from Lactobacillus hilgardii, was used subse-
quently. Different electrocompetence-promoting protocols were
tried, as shown in Fig. 1. Adding the cell wall weakener glycine
(25) at a concentration of 2% to the preculture medium in-
creased the transformation efﬁciency 10-fold. Addition of am-
picillin, also a cell wall weakener (57), during the early expo-
nential growth phase of L. rhamnosus GG led to a 20-fold
increase in the efﬁciency compared to the efﬁciency of an
identical protocol without addition of ampicillin. Addition of
ampicillin was ﬁrst described by Wei et al. (57) for electropo-
ration of Lactobacillus isolates, and this protocol was also used
by McCracken et al. (33) for electroporation of L. rhamnosus
GG. However, in our hands, the protocol described by Wei et
al. (57) did not result in efﬁcient electroporation of L. rham-
nosus GG (data not shown). Compared to the protocol of Wei
et al. (57), we included in our optimization protocol an extra
cell wall weakener, glycine, during the two culture phases, and
we also changed the composition of the washing and electro-
poration buffer, the temperature at which the washing step was
performed, and the electrical parameters used for electropo-
ration (33, 57).
With this optimized protocol, a transformation efﬁciency of
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4 L. rhamnosus GG transformants per g of pLAB1301
DNA was obtained. A similar efﬁciency was obtained for Lac-
tobacillus delbrueckii subsp. bulgaricus (52), but this efﬁciency
was still less than the efﬁciency obtained for L. plantarum (10
6
to 10
7 CFU/g) (14). Perhaps the efﬁciency can still be im-
proved, but 10
4 CFU/g DNA is sufﬁcient to select for double
homologous recombination events, as described by Varmanen
et al. (56) for the construction of a L. rhamnosus 1/6 pepR
mutant. Here, we validated the protocol by overexpressing gfp
under control of the NICE system, resulting in GFP-labeled L.
rhamnosus GG that could be sorted by ﬂuorescence-activated
cell sorting and be used in other applications.
Expression of gfp in L. rhamnosus GG driven by constitutive
promoters. Using the optimized transformation protocol, we
introduced pMEC30 (15) (a pLAB1301 derivative containing
gfpuv under control of the constitutive ldhL promoter from L.
plantarum) into L. rhamnosus GG (transformation efﬁciency,
10
4 CFU/g DNA). pMEC30 could be successfully maintained
in L. rhamnosus GG, as veriﬁed by PCR and plasmid isola-
tion, and subsequently reelectroporated into E. coli. Although
pMEC30 was functional in E. coli, no ﬂuorescent phenotype
was observed in L. rhamnosus GG.
pRV85 was used previously to tag Lactobacillus sakei with
GFP (17). pRV85 (17) could be successfully transferred to L.
rhamnosus GG, as conﬁrmed by PCR and Southern analysis
(data not shown). L. rhamnosus GG cells bearing pRV85 ap-
peared as green ﬂuorescent bacteria in a ﬂuorescence micro-
scopic analysis, albeit with a low intensity (data not shown).
However, pRV85 is a replication-thermosensitive derivative of
pWV01 and replicates in gram-positive bacteria at 28°C and is
lost at temperatures above 37°C (3). Expression of gfp from
pldhL in L. sakei was reported to increase when the culture
temperature was decreased (17). In view of future applications,
optimization of gfp expression by altering the growth temper-
ature of L. rhamnosus GG, which prefers 37°C for growth, was
not pursued.
Also, in L. plantarum gfp expression from a constitutive
promoter appeared not to be feasible (15). We attempted to
express gfp under control of a nisin-inducible promoter, which
was previously reported to be successful in L. plantarum (15).
Expression of gfp in L. rhamnosus GG through implemen-
tation of the NICE system. The nisRK genes with their own
promoter were integrated into the chromosome of L. rhamno-
sus GG. Site-speciﬁc integration was accomplished by electro-
porating the suicide plasmid pMEC10 (42) into L. rhamnosus
GG. It is noteworthy that successful integration was obtained
only with pMEC10 DNA isolated from E. coli GM2163, a
Dam
 Dcm
 strain (unmethylated DNA). Putative integrants,
which were able to grow on erythromycin, were analyzed by
PCR and Southern hybridization (data not shown). No plasmid
DNA containing nisRK could be reisolated. One integrant,
FAJ1905, exhibited the expected tRNA
Ser integration patterns
and was used for further manipulation.
In parallel, we integrated nisRK into the L. rhamnosus GG
chromosome by an alternative method using plasmid pFAJ1934.
The nisRK genes were cloned in pEM40, a nonreplicative inte-
gration vector containing the A2-speciﬁc recombination cassette
int-attP (1). Bacteriophage A2 integrates at the 3 end of the
tRNA
Leu locus. This attachment site allowed integration of A2
attP-containing vectors into the genomes of Lactobacillus casei
and Lactobacillus paracasei (1), both of which are closely related
to L. rhamnosus GG. Transformation of L. rhamnosus GG with
pFAJ1934 and selection for erythromycin-resistant colonies
yielded putative integrants. PCR and Southern hybridization con-
ﬁrmed that there was chromosomal integration of pFAJ1934 at
the corresponding tRNA loci in these clones (data not shown).
One integrant that had the correct structure was selected and
designated FAJ1906.
The two integration plasmids supported successful chromo-
somal insertion at permissive sites based on the integration
properties of a bacteriophage. This method provides an efﬁ-
cient way to generate stable heterologous DNA integration in
L. rhamnosus GG.
Subsequently, pMEC45 (15), the expression vector contain-
ing gfp under control of the nisA promoter, was electroporated
into FAJ1905 and FAJ1906. Transformants were veriﬁed by
PCR analysis (data not shown).
In previous applications of the NICE system in different
species the workers stressed the need for optimization of nisin
induction conditions in each host separately (5, 9, 42). The
FIG. 1. Optimization of the electroporation protocol. The protocol
described by Varmanen et al. (56) for electrotransformation of L.
rhamnosus 1/6, a cheese isolate, was used as a starting point. Using the
originally described protocol with L. rhamnosus GG resulted in an
efﬁciency of only 10
2 CFU/g DNA. By gradually varying the DNA
concentration (0.2 to 3 g DNA) and the voltage applied (1.4 to 2.0
kV) we increased the efﬁciency 10-fold, and the optimal parameter
combination was 400 ng DNA and 1.7 kV. However, pGK13 seemed to
be segregationally unstable in L. rhamnosus GG and was not used
further. Electroporation of L. rhamnosus GG and L. rhamnosus 1/6
using pLAB1301 resulted in reproducible efﬁciencies of 10
2 and 5 

10
5 CFU/g DNA, respectively. The resilience of the peptidoglycan
layer in gram-positive bacteria complicates the development of elec-
troporation protocols (54). The composition of the growth medium
directly affects the cell wall density and thickness. Therefore, weaken-
ing the cell wall by addition of cell wall weakeners, such as glycine (18),
can improve the transformation efﬁciency. We included two culture
steps with 2% glycine in the growth medium. When 2% glycine was
added to the serial dilutions of an overnight culture of L. rhamnosus
GG, the electroporation efﬁciency increased 10-fold compared to the
electroporation efﬁciency of an identical protocol without an overnight
preculture supplemented with glycine. Addition of ampicillin, also a
cell wall weakener (57), during the early exponential growth phase of
L. rhamnosus GG led to a 20-fold increase in the efﬁciency compared
to the efﬁciency of an identical protocol without addition of ampicillin.
4926 DE KEERSMAECKER ET AL. APPL.E NVIRON.M ICROBIOL.optimal growth phase for nisin induction, the optimal contact
time with the inducer, and the optimal nisin concentration for
induction were determined as described previously (42). To
do this, we used the -glucuronidase activity of FAJ1905/
pNZ8008 as a reporter for nisin induction, concomitantly op-
timizing a user-friendly protocol for analysis of gusA expression
in L. rhamnosus GG (see Materials and Methods). The results
are summarized in Fig. 2. As Fig. 2 shows, the maximal levels
of -glucuronidase activity were obtained when the inducer
was added early in the exponential phase, 30 min after inocu-
lation (1/50 inoculum; 37°C), after 2.5 to3ho finduction.
Similar to the situation in L. plantarum (42), L. rhamnosus
GG was most receptive to nisin when it was added very early
in the exponential growth phase; in contrast, in L. lactis
addition in the middle of the exponential growth phase was
more effective (4).
The inoculation and incubation times were optimized as
described by Pavan et al. (42), using 50 ng/ml nisin. However,
the maximum levels of -glucuronidase activity were observed
after induction with 500 ng/ml (ﬁnal concentration) nisin. In
retrospect, this concentration may have been more appropriate
in our study for optimizing the inoculation and incubation
times. Remarkably higher doses of the inducer are necessary
for L. rhamnosus GG (250 to 500 ng/ml) than for L. lactis (1 to
5 ng/ml) (5) or L. plantarum (20 to 25 ng/ml) (42). The optimal
nisin concentrations for L. rhamnosus GG are in the same
range as the concentrations used for induction in Streptococcus
species (1 to 5 g/ml) (9). In Bacillus subtilis and Enterococcus
faecalis, concentrations as high as 20 g/ml are necessary, and
these concentrations are just below the inhibitory level (9). In
addition, the optimal contact times with the inducer are dif-
FIG. 2. -Glucuronidase activity of FAJ1905/pNZ8008 cell extracts. (A) -Glucuronidase activity (solid symbols) was determined during
growth (open symbols) in different conditions (squares, 1/50 inoculum and incubation at 37°C; triangles, 1/20 inoculum and incubation at 30°C;
circles, 1/20 inoculum and incubation at 37°C; diamonds, 1/20 inoculum and incubation at 30°C) after induction with 50 ng of nisin/ml at different
times after inoculation. The -glucuronidase activity was measured after 2.5 h of contact with nisin. (B) -Glucuronidase activity (■ ) after different
periods of contact with 50 ng nisin/ml. The OD600 () was also determined. (C) Dose-response curve for gusA expression in FAJ1905 harboring
pNZ8008 induced with different concentrations of nisin (0 to 5,000 ng/ml). (D) -Glucuronidase activity with nisin concentrations ranging from
0 to 100 ng/ml. -Glucuronidase activity is expressed in Miller units (M.U.), as described in Materials and Methods. The error bars indicate
standard deviations.
FIG. 3. GFP-tagged L. rhamnosus GG, based on implementation
of the NICE system: epiﬂuorescence microscopic analysis of bacterial
cells grown in liquid broth. (A) FAJ1905/pMEC45 induced with nisin
as described in Materials and Methods. (B) FAJ1906/pMEC45 in-
duced with nisin as described in Materials and Methods.
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and 2.5 h (this study), respectively. It has been reported pre-
viously that the optimal contact time with the inducer, leading
to maximal protein production, can vary greatly with the host
(26, 42). The induction factor, deﬁned as the ratio of the
-glucuronidase activity observed after maximal induction to
the basal activity with no inducer, is 500. This value is similar
to values reported for L. plantarum (42), which in turn were
only two- to threefold lower than the values reported for L.
lactis (4).
Using these inducing conditions with FAJ1905/pMEC45 and
FAJ1906/pMEC45 resulted in bright green ﬂuorescent bacte-
ria, as determined by ﬂuorescence microscopy (Fig. 3) and
ﬂow cytometric analysis (Fig. 4). FAJ1905/pMEC45 exhibited
slightly enhanced ﬂuorescence intensity compared to FAJ1906/
pMEC45 (Fig. 4). This could have been due to the two differ-
ent locations of nisRK (i.e., in the tRNA
Ser and tRNA
Leu loci,
respectively).
Use of GFP-tagged L. rhamnosus GG to determine sensitiv-
ity to human beta-defensins. The combination of GFP and PI
has been shown to have some advantages for analysis of bac-
terial viability compared to the frequently used LIVE/DEAD
BacLight bacterial viability kit (31). Here we used the GFP-
PI-based assay for ﬂow cytometric measurement of the viability
of L. rhamnosus GG after contact with human beta-defensins.
Human beta-defensins are antimicrobial peptides expressed by
epithelial cells (30, 50). It is now recognized that beta-de-
fensins are integral components of the constitutive and regu-
lated innate host defense; hBD1 is a constitutively expressed
molecule, while hBD2, hBD3, and hBD4 are upregulated by
bacterial challenge and proinﬂammatory cytokines (38, 39). It
has been reported that constitutively expressed hBD1 can me-
diate epithelial interactions with the commensal ﬂora, whereas
hBD2 may participate in the host defense response to enteric
microbes that can breach the epithelial barrier. Human beta-
defensins are antimicrobial peptides that are particularly efﬁ-
cient in destroying gram-negative bacteria (38), while it has
been reported that a biﬁdobacterial probiotic strain is not
sensitive to human beta-defensin-mediated killing by recombi-
nant hBD1, hBD2, and hBD3 (13). We investigated the effect
of hBD1 and hBD2 on GFP-labeled L. rhamnosus GG using
ﬂow cytometry (Fig. 5). While hBD1 did not kill L. rhamnosus
GG (Fig. 5A), L. rhamnosus GG was very sensitive to hBD2
(Fig. 5A). These results were conﬁrmed by plate counting (Fig.
5B). The sensitivity was directly related to the defensin con-
centration (Fig. 5C). Subsequently, a time course experiment
was performed in order to determine the defensin contact time
required to kill the bacterial cells. At an hBD2 concentration
of 6 g/ml, a decrease in cell viability was observed 2 h after
addition of the defensin to the culture medium. However, at a
concentration of 12 g/ml, L. rhamnosus GG was killed almost
immediately after addition of the defensin (data not shown).
Hudault et al. (20) reported that the number of L. rhamnosus
GG cells in the gut of L. rhamnosus GG-monoassociated mice
was dramatically decreased after a challenge with Salmonella,
but the mechanism behind this phenomenon is unknown. It
could be speculated that Salmonella infection upregulates de-
fensin production (37), which leads to a decrease in the num-
ber of viable L. rhamnosus GG cells and reduced protection
FIG. 4. Flow cytometric analysis of induced (GFP
) and unin-
duced (GFP
) L. rhamnosus GG. FAJ1905/pMEC45 and FAJ1906/
pMEC45 were induced with nisin as described in Materials and Meth-
ods (FAJ1905/pMEC45  nisin and FAJ1906/pMEC45  nisin).
Cultures without nisin were used as negative controls (FAJ1906/
pMEC45 and FAJ1905/pMEC45  nisin). Green ﬂuorescence inten-
sities (FL1-H) are indicated on the x axis, and cell counts are indicated
on the y axis. The cytometric analysis was performed for 2 
 10
4
events.
FIG. 5. Sensitivity of L. rhamnosus GG to human beta-defensins. (A) Bacterial viability of L. rhamnosus GG after3ho fcontact with 12 g/ml
hBD1 or hBD2, as determined by GFP-PI-based ﬂow cytometric analysis. The values are the ratios of the mean intensities of the green (FL-1) and
red (FL-2) signals. The error bars indicate standard deviations of three independent measurements. No human beta-defensin was added to the
control. (B) Bacterial viability of L. rhamnosus GG after3ho fcontact with 12 g/ml hBD1 or hBD2, as determined by plate counting. The values
are percentages of survival of the initial number of L. rhamnosus GG cells. The error bars indicate standard deviations of three independent
measurements. (C) Concentration-dependent sensitivity of L. rhamnosus GG to hBD2, as determined by GFP-PI-based ﬂow cytometric analysis
as described above.
4928 DE KEERSMAECKER ET AL. APPL.E NVIRON.M ICROBIOL.against the pathogen. Therefore, incorporation of a screen for
defensin resistance in the selection of probiotic strains could be
appropriate.
Concluding remarks. Although there have been many stud-
ies of L. rhamnosus GG and L. rhamnosus GG has been used
in numerous clinical trials, molecular genetic analysis of L.
rhamnosus GG is poorly developed. This fact can be explained
in part by the lack of a reliable transformation procedure. In
this paper, we describe a reproducible electroporation protocol
for L. rhamnosus GG. This protocol enabled us to implement
the NICE system in L. rhamnosus GG and subsequently label
this strain with GFP. As previously shown (15), preloaded
ﬂuorescent bacteria can be used for a variety of in vitro and in
vivo experiments, including studies of the interaction of L.
rhamnosus GG with members of the microbiota and with spe-
ciﬁc members of the immune system. Here, we used preloaded
ﬂuorescent bacteria to show L. rhamnosus GG sensitivity to
hBD2.
The ﬂexibility of the L. rhamnosus GG NICE system should
allow expression of other genes of interest under control of the
nisA promoter. This could be used to increase the technolog-
ical suitability of L. rhamnosus GG by food-grade (nisin is a
food-grade, approved antibiotic peptide) genetic manipulation
approaches (46), as shown by overexpression of the GroESL
heat shock protein chaperones in Lactobacillus paracasei NFBC338
(6). Moreover, this system could be used for development and
design of live recombinant vaccines (51) in which L. rhamnosus
GG is used as a live delivery vehicle. Thus, the implementation
of the NICE system in L. rhamnosus GG provides an approach
for improving and expanding both the technical performance
and the probiotic performance of this strain.
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